Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05316935 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Name: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients — clinical trial record (NCT05316935)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2/3

SponsorXiaojun Chen

Started2022-07-13

View on ClinicalTrials.gov ↗

To investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-stage endometrial cancer (EEC) and atypical hyperplasia(EAH) patients asking for conservative treatment.

Amendment history 2 changes detected by DataLookout

2026-09-11

Primary completion pushed: 2026-03-30 → 2028-03-30

2026-09-11

Completion pushed: 2027-03-30 → 2028-03-30

Trial Details

NCT Number	NCT05316935
Lead Sponsor	Xiaojun Chen
Conditions	Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance
Enrollment	80 participants
Start Date	2022-07-13
Primary Completion	2028-03-30 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-10